Glenmark unit gets US nod for lithium carbonate capsules
MUMBAI, Feb 4 (Reuters) - Glenmark Pharmaceuticals Ltd's (GLEN.BO: Quote, Profile, Research) unit, Glenmark Generics, said on Wednesday it received the U.S. Food and Drug Administration approval to sell lithium carbonate capsules in multiple strengths.
The drug is used in the treatment of bipolar disorders and had annual sales of $10 million, the company added in a statememt. (Reporting by Bharghavi Nagaraju; editing by Sunil Nair)
© Thomson Reuters 2010 All rights reserved
Economy seen growing at 7.2 pct in FY10 - govt
The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget. Full Article
Greek crisis sets euro zone enlargement back
The Greek debt crisis has dealt a setback to prospects of enlarging the euro zone by highlighting the difficulties of managing the single currency area. Full Article
India
US
UK
